Market closedNon-fractional
Medtronic/MDT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Medtronic
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Ticker
MDT
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Dublin, Ireland
Employees
95,000
Website
www.medtronic.com
Medtronic Metrics
BasicAdvanced
$101B
Market cap
28.43
P/E ratio
$2.76
EPS
0.83
Beta
$2.76
Dividend rate
3.52%
Dividend yield
Price and volume
Market cap
$101B
Beta
0.83
Dividend rate
$2.76
Financial strength
Current ratio
2.033
Quick ratio
1.31
Long term debt to equity
47.465
Total debt to equity
49.631
Dividend payout ratio (TTM)
99.73%
Interest coverage (TTM)
8.98%
Management effectiveness
Return on assets (TTM)
4.46%
Return on equity (TTM)
7.26%
Valuation
Price to earnings (TTM)
28.428
Price to revenue (TTM)
3.219
Price to book
2.05
Price to tangible book (TTM)
-25.75
Price to free cash flow (TTM)
20.033
Dividend yield (TTM)
3.52%
Growth
Revenue change (TTM)
3.64%
Earnings per share change (TTM)
-2.13%
3-year revenue growth (CAGR)
2.43%
3-year earnings per share growth (CAGR)
1.24%
3-year dividend per share growth (CAGR)
5.96%
What the Analysts think about Medtronic
Analyst Ratings
Majority rating from 34 analysts.
Medtronic Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q4 24
QoQ growth
Revenue
$8.6B
6.18%
Net income
$654M
-50.53%
Profit margin
7.61%
-53.43%
Medtronic Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Actual
$1.20
$1.25
$1.30
$1.46
-
Expected
$1.11
$1.18
$1.26
$1.45
$1.20
Surprise
8.24%
5.86%
3.13%
0.69%
-
Medtronic News
AllArticlesVideos
Grab These 5 Overlooked Dividend Aristocrats Before Wall Street Catches On
24/7 Wall Street·2 days ago
Medtronic: Lock In This Dividend Aristocrat While It's Still Cheap
Seeking Alpha·1 week ago
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Medtronic stock?
Medtronic (MDT) has a market cap of $101B as of July 27, 2024.
What is the P/E ratio for Medtronic stock?
The price to earnings (P/E) ratio for Medtronic (MDT) stock is 28.43 as of July 27, 2024.
Does Medtronic stock pay dividends?
Yes, the Medtronic (MDT) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $2.76 and the yield is 3.52%. Medtronic has a payout ratio of 99.73% on a trailing twelve-month basis.
When is the next Medtronic dividend payment date?
The next Medtronic (MDT) dividend payment date is unconfirmed.
What is the beta indicator for Medtronic?
Medtronic (MDT) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Medtronic stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.